Clinical experience with hemofiltration

Clinical Experience with Aureomycin.

Clinical review: Alternative vascular access techniques for continuous hemofiltration

Obtaining or maintaining vascular access for continuous hemofiltration can sometimes be problematic, especially in the child or adult in multiple organ failure with edema and/or coagulopathy. Problems commonly encountered include obstruction of the femoral vein by the catheter, insertion difficulties, safety concerns when cannulating the subclavian vein in coagulopathy, and catheter and circuit...

Clinical Experience with Surital Sodium*

StrmWAL sodium was introduced to the Canadian market this year as a proven intravenous anaesthetic agent. For thls reaso-ff~it was f~lt timely to discuss the place of Surital m present day clinical anaesthesia. It is gratifying to note that Surital has had a long and careful laboratory and clinical trial, over a period of seven years, before it was released to the open market. There have been f...

Clinical experience with pegaptanib sodium

Pegaptanib sodium (Macugen((R))) blocks the extracellular vascular endothelial growth factor (VEGF) isoform VEGF(165), whose elevated levels are associated with the development of choroidal neovascularization (CNV). This selective inhibition prevents binding to the VEGF receptors and the development of the increased vascular permeability and the CNV associated with neovascular age-related degen...

Clinical experience with 6-aminonicotinamide.

The toxicity of 6-Aminonicotinamide in 60 patients with advanced malignant disease has been described. The toxicity took two clinical forms: a "deficiency" state with char acteristics of a mixed B-complex vitamin deficiency, and a neurologic disturbance pre sumably due to a direct action on the central nervous system. Individual susceptibility was widely variable. 6-Aminonicotinamide exhibited ...